Skip to main content
profile image for
  • Chief, Division of Kidney Disease and Hypertension, Northwell Health
  • Vice President, Northwell Health for Network Dialysis Services, Northwell Health
  • Professor of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

About the investigator

Steven Fishbane is the chief of nephrology of Northwell Health and Professor of Medicine at the Zucker School of Medicine. As a nephrologist with over 25 years of clinical experience and over 24 years as a medical researcher with more than 210 peer-reviewed publications, he understands and has studied many of the issues involved with patient hospitalizations,, readmissions, complications of chronic kidney disease (CKD) and issues with decision making related to end stage kidney disease (ESKD). An important part of his training has been as medical director for 5 different dialysis facilities and as Medical Director for the Healthy Transitions in Advanced Kidney Disease Program. He has been the recipient of multiple honors and holds several appointments, including to the National Quality Forum’s Standing Committee of Admissions and Readmissions. Through his clinical research, Dr. Fishbane has become renowned for advancement and innovation in the treatment of CKD patients.

Dr. Fishbane received his MD and trained in nephrology at Albert Einstein College of Medicine. 

Research focus

  • Hyperkalemia management complications of kidney disease
  • Inflammation in kidney disease
  • Quality management in kidney disease anemia and iron management
  • Outcomes of kidney disease

Education

Albert Einstein College of Medicine
Degree: MD
1988

Columbia University
Degree: Premedical courses
1984

University of Miami
Degree: BBA
1981
Field of study: Computer science & accounting

Lab members

Azzour Hazzan
Associate Chairperson
Email: [email protected]

Julton Tomanguillo Chambe
Senior Research Coordinator
Email: [email protected]

Honors & awards

  • 2012 Nephrologist of the Year, American Kidney Fund
  • 2007-present Castle Connelly Top Doctors
  • 2004-Present Best Doctors
  • 2003-2004 Best Doctors
  • 2002-2003 Best Doctors
  • 2002 Physician Leadership in Quality Improvement, IPRO
  • 1998 Alpha Omega Alpha, Elected
  • 1994 Outstanding Teaching Attending Award, Winthrop-University Hospital
  • 1990 Outstanding Resident Award, Montefiore Hospital

Publications

  1. Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia. J Am Soc Nephrol. 2019 Jun 14
  2. Block GA, Pergola PE, Fishbane S, Martins JG, LeWinter RD, Uhlig K, Neylan JF, Chertow GM. Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses. Nephrol Dial Transplant. 2019 Jul 1;34(7):1115-1124.
  3. Ibrahim J, Hazzan AD, Mathew AT, Sakhiya V, Zhang M, Halinski C, Fishbane S. Medication discrepancies in late-stage chronic kidney disease. Clin Kidney J. 2018 Aug;11(4):507-512.
  4. Fishbane S, Spinowitz B. Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. Am J Kidney Dis. 2018 Mar;71(3):423-435.
  5. Locatelli F, Hannedouche T, Fishbane S, Morgan Z, Oguey D, White WB. Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial. Clin J Am Soc Nephrol. 2019 Aug 16.